DOID:1192

Name:	peripheral nervous system neoplasm
Namespace:	FANTOM
Definition:	"A nervous system cancer that is located_in the peripheral nervous system." [url:http://en.wikipedia.org/wiki/Peripheral_nervous_system]
Xrefs:	links: MSH:D010524 NCI:C3321 SNOMEDCT_2010_1_31:115242003 SNOMEDCT_2010_1_31:126980002 SNOMEDCT_2010_1_31:134214003 SNOMEDCT_2010_1_31:189946005 SNOMEDCT_2010_1_31:189953001 UMLS_CUI:C0031118 UMLS_CUI:C0206727
Synonyms:	"neoplasm of peripheral nerve (disorder)" EXACT [SNOMEDCT_2005_07_31:126980002] "nerve sheath neoplasm" EXACT [CSP2005:2012-6947] "nerve sheath tumor (morphologic abnormality)" EXACT [SNOMEDCT_2005_07_31:115242003] "nerve sheath tumor [dup] (morphologic abnormality)" EXACT [SNOMEDCT_2005_07_31:134214003] "nerve sheath tumor NOS (morphologic abnormality)" EXACT [SNOMEDCT_2005_07_31:189953001] "nerve sheath tumors" EXACT [] "tumor of PNS" EXACT [NCI2004_11_17:C3321]
Alt_id:	DOID:3194

Ontology association<br>Each term has an is_a parent in the Disease Ontology, which has a linkage to an another entity and FANTOM5 samples.Libraries were grouped into mutually exclusive facets according to the FANTOM5 sample ontology mapping to DISEASE ontologies.<br><br>link to ontology dataset<br>data

---

Parents

is_a:	DOID:3093(nervous system cancer)

Children

is a:	DOID:2621 (autonomic nervous system neoplasm),DOID:3193 (peripheral nerve sheath neoplasm),DOID:3369 (peripheral primitive neuroectodermal tumor)

Ontology Tree: Loaded from BioPortal

Ontorolgy tree(Small window open)

FF samples

Human (Homo sapiens)

• 10460-106H1
• 10585-108C9
• 10705-109H3 (Ewing's sarcoma cell line:Hs 863.T)
• 10728-110A8 (neuroepithelioma cell line:SK-N-MC)
• 10729-110A9 (neurofibroma cell line:Hs 53.T)

Mouse (Mus musculus)

• 10460-106H1
• 10585-108C9
• 10705-109H3 (Ewing's sarcoma cell line:Hs 863.T)
• 10728-110A8 (neuroepithelioma cell line:SK-N-MC)
• 10729-110A9 (neurofibroma cell line:Hs 53.T)

Enrichment analysis: top 100 FFCP enriched with this ontology termTOP 100 FANTOM5 Cage Peaks enriched with DOID:1192 (peripheral nervous system neoplasm), sorted by p-values <br>Analyst: Hideya Kawaji<br><br>link to source dataset <br>human : data <br>mouse : data

---

Copy Excel CSV PDF

Show 102550100 entries

Search:

P-value	FFCP	Short description

P-value	FFCP	Short description
2.39e-66	FFCP PHASE1:Hg19::chr1:21339635..21339636,-	p@chr1:21339635..21339636, -
2.39e-66	FFCP PHASE2:Hg19::chr1:21339635..21339636,-	p@chr1:21339635..21339636, -
4.27e-34	FFCP PHASE2:Hg19::chr8:12808791..12808798,+	p28@KIAA1456
4.27e-34	FFCP PHASE1:Hg19::chr8:37824442..37824447,-	p9@ADRB3
4.27e-34	FFCP PHASE2:Hg19::chr8:37824442..37824447,-	p9@ADRB3
4.27e-34	FFCP PHASE1:Hg19::chr1:22696471..22696505,-	p@chr1:22696471..22696505, -
4.27e-34	FFCP PHASE2:Hg19::chr1:22696471..22696505,-	p@chr1:22696471..22696505, -
4.27e-34	FFCP PHASE1:Hg19::chr8:12808791..12808798,+	p28@KIAA1456
5.96e-34	FFCP PHASE2:Hg19::chr6:21203484..21203485,+	p@chr6:21203484..21203485, +
5.96e-34	FFCP PHASE2:Hg19::chr12:45444635..45444645,-	p2@AB463567
5.96e-34	FFCP PHASE1:Hg19::chr2:242742205..242742253,+	p@chr2:242742205..242742253, +
5.96e-34	FFCP PHASE2:Hg19::chr7:91509972..91509984,-	p3@MTERF
5.96e-34	FFCP PHASE2:Hg19::chr8:37824009..37824022,-	p3@ADRB3
5.96e-34	FFCP PHASE1:Hg19::chr8:37824071..37824078,-	p5@ADRB3
5.96e-34	FFCP PHASE2:Hg19::chr18:56886837..56886844,+	p@chr18:56886837..56886844, +
5.96e-34	FFCP PHASE2:Hg19::chr8:27041770..27041779,+	p4@ENST00000521408
5.96e-34	FFCP PHASE2:Hg19::chr2:242742205..242742253,+	p@chr2:242742205..242742253, +
5.96e-34	FFCP PHASE2:Hg19::chr12:69678255..69678259,+	p1@ENST00000548895
5.96e-34	FFCP PHASE1:Hg19::chr18:56886837..56886844,+	p@chr18:56886837..56886844, +
5.96e-34	FFCP PHASE2:Hg19::chr8:37824071..37824078,-	p5@ADRB3
5.96e-34	FFCP PHASE1:Hg19::chr12:45444635..45444645,-	p2@AB463567
5.96e-34	FFCP PHASE1:Hg19::chr4:155299368..155299375,-	p@chr4:155299368..155299375, -
5.96e-34	FFCP PHASE1:Hg19::chr12:69678255..69678259,+	p1@ENST00000548895
5.96e-34	FFCP PHASE1:Hg19::chr3:193615743..193615750,-	p@chr3:193615743..193615750, -
5.96e-34	FFCP PHASE2:Hg19::chr17:39023472..39023477,-	p1@KRT12
5.96e-34	FFCP PHASE2:Hg19::chr4:155299368..155299375,-	p@chr4:155299368..155299375, -
5.96e-34	FFCP PHASE1:Hg19::chr6:104346803..104346806,-	p@chr6:104346803..104346806, -
5.96e-34	FFCP PHASE2:Hg19::chr3:193615743..193615750,-	p@chr3:193615743..193615750, -
5.96e-34	FFCP PHASE1:Hg19::chr8:40273499..40273504,-	p@chr8:40273499..40273504, -
5.96e-34	FFCP PHASE1:Hg19::chr17:39023472..39023477,-	p1@KRT12
5.96e-34	FFCP PHASE1:Hg19::chrX:52006984..52006993,+	p@chrX:52006984..52006993, +
5.96e-34	FFCP PHASE2:Hg19::chr6:104346803..104346806,-	p@chr6:104346803..104346806, -
5.96e-34	FFCP PHASE1:Hg19::chr7:91509972..91509984,-	p3@MTERF
5.96e-34	FFCP PHASE1:Hg19::chr8:37824009..37824022,-	p3@ADRB3
5.96e-34	FFCP PHASE1:Hg19::chr8:27041770..27041779,+	p4@ENST00000521408
5.96e-34	FFCP PHASE2:Hg19::chr8:40273499..40273504,-	p@chr8:40273499..40273504, -
5.96e-34	FFCP PHASE2:Hg19::chrX:52006984..52006993,+	p@chrX:52006984..52006993, +
5.96e-34	FFCP PHASE1:Hg19::chr6:21203484..21203485,+	p@chr6:21203484..21203485, +
1.71e-30	FFCP PHASE2:Hg19::chr17:48262286..48262289,-	p@chr17:48262286..48262289, -
1.71e-30	FFCP PHASE1:Hg19::chr17:48262286..48262289,-	p@chr17:48262286..48262289, -
2.67e-30	FFCP PHASE1:Hg19::chrX:606157..606161,+	p@chrX:606157..606161, +
2.67e-30	FFCP PHASE2:Hg19::chrX:606157..606161,+	p@chrX:606157..606161, +
1.59e-27	FFCP PHASE2:Hg19::chr4:39501682..39501693,-	p24@UGDH
1.59e-27	FFCP PHASE1:Hg19::chr4:39501682..39501693,-	p24@UGDH
2.72e-27	FFCP PHASE2:Hg19::chr15:33023519..33023526,+	p@chr15:33023519..33023526, +
2.72e-27	FFCP PHASE1:Hg19::chr15:33023519..33023526,+	p@chr15:33023519..33023526, +
5.5e-25	FFCP PHASE1:Hg19::chr5:83670631..83670634,+	p@chr5:83670631..83670634, +
5.5e-25	FFCP PHASE2:Hg19::chr5:83670631..83670634,+	p@chr5:83670631..83670634, +
6.22e-25	FFCP PHASE1:Hg19::chr16:69958959..69958971,+	p6@WWP2
6.22e-25	FFCP PHASE2:Hg19::chr16:69958959..69958971,+	p6@WWP2
2.62e-23	FFCP PHASE2:Hg19::chr13:38136724..38136726,+	p@chr13:38136724..38136726, +
2.62e-23	FFCP PHASE1:Hg19::chr8:37824176..37824185,-	p4@ADRB3
2.62e-23	FFCP PHASE1:Hg19::chr5:147011027..147011032,-	p@chr5:147011027..147011032, -
2.62e-23	FFCP PHASE2:Hg19::chr17:39023189..39023197,-	p2@KRT12
2.62e-23	FFCP PHASE1:Hg19::chr13:38136724..38136726,+	p@chr13:38136724..38136726, +
2.62e-23	FFCP PHASE2:Hg19::chr8:37824176..37824185,-	p4@ADRB3
2.62e-23	FFCP PHASE1:Hg19::chr17:39023189..39023197,-	p2@KRT12
2.62e-23	FFCP PHASE2:Hg19::chr5:147011027..147011032,-	p@chr5:147011027..147011032, -
2.62e-23	FFCP PHASE1:Hg19::chr5:147011039..147011055,-	p@chr5:147011039..147011055, -
2.62e-23	FFCP PHASE2:Hg19::chr19:49915463..49915468,+	p@chr19:49915463..49915468, +
2.62e-23	FFCP PHASE2:Hg19::chr5:147011039..147011055,-	p@chr5:147011039..147011055, -
2.62e-23	FFCP PHASE1:Hg19::chr19:49915463..49915468,+	p@chr19:49915463..49915468, +
2.62e-23	FFCP PHASE1:Hg19::chr5:147011082..147011102,-	p@chr5:147011082..147011102, -
2.62e-23	FFCP PHASE2:Hg19::chr5:147011082..147011102,-	p@chr5:147011082..147011102, -
3.27e-23	FFCP PHASE1:Hg19::chrX:2715135..2715149,+	p@chrX:2715135..2715149, +
3.27e-23	FFCP PHASE2:Hg19::chrX:2715135..2715149,+	p@chrX:2715135..2715149, +
3.27e-23	FFCP PHASE1:Hg19::chr7:119353807..119353812,-	p@chr7:119353807..119353812, -
3.27e-23	FFCP PHASE2:Hg19::chr7:119353807..119353812,-	p@chr7:119353807..119353812, -
3.27e-23	FFCP PHASE2:Hg19::chr1:114654778..114654823,+	p@chr1:114654778..114654823, +
3.27e-23	FFCP PHASE2:Hg19::chr10:72538478..72538484,-	p@chr10:72538478..72538484, -
3.27e-23	FFCP PHASE1:Hg19::chr8:37560262..37560269,-	p@chr8:37560262..37560269, -
3.27e-23	FFCP PHASE1:Hg19::chr1:18957380..18957386,+	p10@PAX7
3.27e-23	FFCP PHASE2:Hg19::chr1:18957380..18957386,+	p10@PAX7
3.27e-23	FFCP PHASE1:Hg19::chr20:21087017..21087026,-	p3@LINC00237
3.27e-23	FFCP PHASE1:Hg19::chr1:114654778..114654823,+	p@chr1:114654778..114654823, +
3.27e-23	FFCP PHASE2:Hg19::chr8:37560262..37560269,-	p@chr8:37560262..37560269, -
3.27e-23	FFCP PHASE2:Hg19::chr20:21087017..21087026,-	p3@LINC00237
3.27e-23	FFCP PHASE1:Hg19::chr10:72538478..72538484,-	p@chr10:72538478..72538484, -
4.09e-23	FFCP PHASE1:Hg19::chr2:212586166..212586168,-	p@chr2:212586166..212586168, -
4.09e-23	FFCP PHASE1:Hg19::chr11:126898086..126898090,-	p@chr11:126898086..126898090, -
4.09e-23	FFCP PHASE1:Hg19::chr17:31624987..31624990,+	p@chr17:31624987..31624990, +
4.09e-23	FFCP PHASE1:Hg19::chr19:48876418..48876427,+	p@chr19:48876418..48876427, +
4.09e-23	FFCP PHASE2:Hg19::chr9:15885823..15885844,+	p@chr9:15885823..15885844, +
4.09e-23	FFCP PHASE1:Hg19::chr13:33760224..33760234,-	p15@STARD13
4.09e-23	FFCP PHASE2:Hg19::chr2:212586166..212586168,-	p@chr2:212586166..212586168, -
4.09e-23	FFCP PHASE1:Hg19::chr2:4634459..4634466,+	p@chr2:4634459..4634466, +
4.09e-23	FFCP PHASE2:Hg19::chr13:114108187..114108229,-	p12@ADPRHL1
4.09e-23	FFCP PHASE1:Hg19::chr2:72803155..72803204,-	p@chr2:72803155..72803204, -
4.09e-23	FFCP PHASE1:Hg19::chr8:128808429..128808430,+	p@chr8:128808429..128808430, +
4.09e-23	FFCP PHASE2:Hg19::chr2:4634459..4634466,+	p@chr2:4634459..4634466, +
4.09e-23	FFCP PHASE1:Hg19::chr13:114108187..114108229,-	p12@ADPRHL1
4.09e-23	FFCP PHASE1:Hg19::chr2:234699525..234699537,+	p@chr2:234699525..234699537, +
4.09e-23	FFCP PHASE2:Hg19::chr2:72803155..72803204,-	p@chr2:72803155..72803204, -
4.09e-23	FFCP PHASE1:Hg19::chr8:27009314..27009357,-	p@chr8:27009314..27009357, -
4.09e-23	FFCP PHASE2:Hg19::chr8:128808429..128808430,+	p@chr8:128808429..128808430, +
4.09e-23	FFCP PHASE1:Hg19::chr8:144099758..144099767,-	p4@ENST00000522060
4.09e-23	FFCP PHASE2:Hg19::chr11:126898086..126898090,-	p@chr11:126898086..126898090, -
4.09e-23	FFCP PHASE2:Hg19::chr2:234699525..234699537,+	p@chr2:234699525..234699537, +
4.09e-23	FFCP PHASE2:Hg19::chr8:27009314..27009357,-	p@chr8:27009314..27009357, -
4.09e-23	FFCP PHASE2:Hg19::chr8:144099758..144099767,-	p4@ENST00000522060

Showing 1 to 100 of 100 entries